182 related articles for article (PubMed ID: 591069)
21. Management of sulphone-resistant lepromatous leprosy.
Jopling WH
Lepr Rev; 1977 Jun; 48(2):127-8. PubMed ID: 330998
[No Abstract] [Full Text] [Related]
22. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
23. Transformation from lepromatous to borderline leprosy under clofazimine therapy.
Mahapatra SB; Ramu G
Lepr India; 1976 Apr; 48(2):172-6. PubMed ID: 1022964
[TBL] [Abstract][Full Text] [Related]
24. An immunoperoxidase study of immunological factors in high immune and low resistance granulomas in leprosy.
Ridley MJ; Russell D
J Pathol; 1982 Jun; 137(2):149-57. PubMed ID: 7045310
[TBL] [Abstract][Full Text] [Related]
25. Lucio's phenomenon: another case reported in Brazil.
Monteiro R; Abreu MA; Tiezzi MG; Roncada EV; Oliveira CC; Ortigosa LC
An Bras Dermatol; 2012; 87(2):296-300. PubMed ID: 22570037
[TBL] [Abstract][Full Text] [Related]
26. Peroxidase deficiency in histiocytes of patients with nodular lepromatous leprosy.
Gómez-Estrada H; Morales-Ortiz R; González-Mendoza A; Barba-Rubio J; Ceja-Mendoza S
Arch Invest Med (Mex); 1983; 14(2):127-37. PubMed ID: 6639255
[No Abstract] [Full Text] [Related]
27. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
[TBL] [Abstract][Full Text] [Related]
28. Localization and retention of mycobacterial antigen in lymph nodes of leprosy patients.
Barros U; Ladiwala U; Birdi TJ; Antia NH
Br J Exp Pathol; 1987 Oct; 68(5):733-41. PubMed ID: 3318906
[TBL] [Abstract][Full Text] [Related]
29. Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis.
Near KA; Lefford MJ
J Clin Microbiol; 1992 May; 30(5):1105-10. PubMed ID: 1583106
[TBL] [Abstract][Full Text] [Related]
30. Erythema nodosum leprosum: reactional leprosy.
Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
[TBL] [Abstract][Full Text] [Related]
31. T regulatory cells (TREG)(TCD4+CD25+FOXP3+) distribution in the different clinical forms of leprosy and reactional states.
Parente JN; Talhari C; Schettini AP; Massone C
An Bras Dermatol; 2015; 90(1):41-7. PubMed ID: 25672298
[TBL] [Abstract][Full Text] [Related]
32. Serum beta-glucuronidase in subtypes of leprosy.
George J; Rajendran M; Bhatia VN
Indian J Med Res; 1990 Mar; 91():106-10. PubMed ID: 2345017
[TBL] [Abstract][Full Text] [Related]
33. Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.
Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
Am J Trop Med Hyg; 1975 May; 24(3):485-95. PubMed ID: 1098496
[TBL] [Abstract][Full Text] [Related]
34. Dermal ultrastructure in leprosy.
Van Hale HM; Turkel SB; Rea TH
Arch Pathol Lab Med; 1984 May; 108(5):383-6. PubMed ID: 6546861
[TBL] [Abstract][Full Text] [Related]
35. A statistical analysis of two chemotherapy trials in lepromatous leprosy. II. Interactions among patient variables.
Am J Trop Med Hyg; 1978 Sep; 27(5):1015-8. PubMed ID: 362951
[TBL] [Abstract][Full Text] [Related]
36. Lucio's phenomenon.
Pursley TV; Jacobson RR
Arch Dermatol; 1980 Feb; 116(2):201-4. PubMed ID: 7356353
[TBL] [Abstract][Full Text] [Related]
37. The continuous bacteremia of lepromatous leprosy.
Drutz DJ; Chen TS; Lu WH
N Engl J Med; 1972 Jul; 287(4):159-64. PubMed ID: 4555967
[No Abstract] [Full Text] [Related]
38. The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues.
Rambukkana A; Burggraaf JD; Faber WR; Harboe M; Teeling P; Krieg S; Das PK
Infect Immun; 1993 May; 61(5):1835-45. PubMed ID: 7682995
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical staining of macrophages in the skin lesions of leprosy: the role of antibody to mycobacteria in human serum and various polyclonal immune rabbit antisera.
Kahn HJ; Thorner P; Baumal R; Yeger H; Bailey D; Marks A; From L; Fisher BK; Lynde C
Histochem J; 1985 Sep; 17(9):1009-20. PubMed ID: 3905721
[TBL] [Abstract][Full Text] [Related]
40. Thymus-dependent lymphocytes in leprosy. II. Effect of chemotherapy on T-lymphocyte subpopulations.
Mshana RN; Haregewoin A; Belehu A
J Clin Immunol; 1982 Apr; 2(2):69-74. PubMed ID: 7040440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
